02 Sep 2019 14:13 CET
Novo Nordisk A/S – Share repurchase programme
Novo Nordisk A/S – Share repurchase programme
Bagsværd, Denmark, 2 September 2019 – On 9 August 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 1 February 2019.
Under the programme initiated 9 August 2019, Novo Nordisk will repurchase B shares for an amount up to DKK 2.6 billion in the period from 9 August 2019 to 30 October 2019.
Since the announcement as of 26 August 2019, the following transactions have been made:
Number of
B shares Average
purchase price Transaction
value, DKK
Accumulated, last announcement 1,439,000 495,674,057
26 August 2019 120,000 351.62 42,194,706
27 August 2019 120,000 352.45 42,293,435
28 August 2019 120,000 352.65 42,317,727
29 August 2019 125,000 355.53 44,440,899
30 August 2019 130,000 351.68 45,717,776
Accumulated under the programme 2,054,000 712,638,600